-
公开(公告)号：ES2328559T3
公开(公告)日：2009-11-16
申请号：ES02079004
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/431 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/473 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: Uso de ritonavir o una sal farmacéuticamente aceptable del mismo para mejorar la farmacocinética de un fármaco (o una sal farmacéuticamente aceptable del mismo) que se metaboliza por citocromo P450 monooxigenasa.
-
公开(公告)号：ES2304416T3
公开(公告)日：2008-10-16
申请号：ES02079003
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/13 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: Una combinación de ritonavir o una sal farmacéuticamente aceptable del mismo y un fármaco que es metabolizado por citocromo P450 monooxigenasa 3A4, para mejorar la farmacocinética del fármaco, siempre que el fármaco sea distinto a un inhibidor de VIH proteasa.
-
公开(公告)号：HK1053782A1
公开(公告)日：2003-11-07
申请号：HK03104298
申请日：1999-04-07
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: C07D243/04 , A61K20100101 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/426 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
公开(公告)号：DE69637511T2
公开(公告)日：2009-06-04
申请号：DE69637511
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/13 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
公开(公告)号：DK1284140T3
公开(公告)日：2008-08-18
申请号：DK02079003
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J , NORBECK DANIEL W
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/13 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
Patent Agency Ranking
公开(公告)号：AT392895T
公开(公告)日：2008-05-15
申请号：AT02079003
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/13 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
公开(公告)号：PT1293207E
公开(公告)日：2009-08-11
申请号：PT02079004
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： LEONARD JOHN M , BERTZ RICHARD J , KEMPF DALES J , NORBECK DANIEL W
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/431 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/473 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
-
公开(公告)号：DK1293207T3
公开(公告)日：2009-10-05
申请号：DK02079004
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/431 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/473 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
公开(公告)号：DE69637976D1
公开(公告)日：2009-09-03
申请号：DE69637976
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/431 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/473 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
公开(公告)号：DE69637511D1
公开(公告)日：2008-06-05
申请号：DE69637511
申请日：1996-06-28
Applicant: ABBOTT LAB
Inventor： NORBECK DANIEL W , KEMPF DALES J , LEONARD JOHN M , BERTZ RICHARD J
IPC: A61K31/426 , C07D243/04 , A61K31/335 , A61K31/336 , A61K31/337 , A61K31/34 , A61K31/341 , A61K31/395 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/453 , A61K31/47 , A61K31/472 , A61K31/498 , A61K31/535 , A61K31/5375 , A61K31/55 , A61K31/7048 , A61K38/05 , A61K38/06 , A61K38/13 , A61K38/55 , A61P31/12 , A61P31/18 , C07D217/22 , C07D277/24 , C07D277/28 , C07D295/08 , C07D295/18 , C07D303/46 , C07D307/20 , C07D401/14 , C07D417/12 , C08F2/34
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.02 seconds)
